71 related articles for article (PubMed ID: 29260365)
1. Preoperative [F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer.
Chung HH; Kwon HW; Kang KW; Kim JW; Park NH; Song YS; Kang SB
J Gynecol Oncol; 2012 Jan; 23(1):28-34. PubMed ID: 22355464
[TBL] [Abstract][Full Text] [Related]
2. Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
Braun C; Grünig H; Peikert J; Strobel K; Christmann-Schmid C; Brambs C
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():13-19. PubMed ID: 38394714
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Akamine T; Nakagawa K; Ito K; Watanabe H; Yotsukura M; Yoshida Y; Yatabe Y; Kusumoto M; Watanabe SI
Ann Surg Oncol; 2024 Jan; 31(1):192-200. PubMed ID: 37743455
[TBL] [Abstract][Full Text] [Related]
4. Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study.
Laasik M; Kemppainen J; Auranen A; Hietanen S; Grénman S; Seppänen M; Hynninen J
Cancer Imaging; 2019 May; 19(1):27. PubMed ID: 31142357
[TBL] [Abstract][Full Text] [Related]
5. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prognoses according to non-positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
Maeda O; Miyata-Takata T; Shibata K; Kajiyama H; Mizuno M; Tamakoshi K; Shimoyama Y; Nakamura S; Kikkawa F
Cancer Med; 2016 Jun; 5(6):1081-92. PubMed ID: 26993048
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer.
Park K; Kwon JY; Song JM; Pyeon SY; Lee SH; Chung YS; Lee JM
PLoS One; 2024; 19(5):e0299205. PubMed ID: 38805507
[TBL] [Abstract][Full Text] [Related]
8. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract][Full Text] [Related]
9.
Dang YZ; Li X; Ma YX; Li XL; Yang T; Lu WL; Huang SG
Oncol Lett; 2019 Jan; 17(1):149-158. PubMed ID: 30655750
[TBL] [Abstract][Full Text] [Related]
10. A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer.
Métairie M; Benoit L; Koual M; Bentivegna E; Wohrer H; Bolze PA; Kerbage Y; Raimond E; Akladios C; Carcopino X; Canlorbe G; Uzan J; Lavoué V; Mimoun C; Huchon C; Koskas M; Costaz H; Margueritte F; Dabi Y; Touboul C; Bendifallah S; Ouldamer L; Delanoy N; Nguyen-Xuan HT; Bats AS; Azaïs H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765667
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract][Full Text] [Related]
12. Novel predictors for identifying cervical minimal deviation adenocarcinoma patients with poor prognosis: a long-term observational study in a tertiary centre.
Bao Y; Zhang H; Huang W; Luo X; Yao L; Feng G; Yuan L
Arch Gynecol Obstet; 2024 Apr; 309(4):1483-1490. PubMed ID: 37695371
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors Influencing Survival in Ovarian Cancer Patients: A 10-Year Retrospective Study.
Andreou M; Kyprianidou M; Cortas C; Polycarpou I; Papamichael D; Kountourakis P; Giannakou K
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136256
[TBL] [Abstract][Full Text] [Related]
14. Preoperative CECT-Based Multitask Model Predicts Peritoneal Recurrence and Disease-Free Survival in Advanced Ovarian Cancer: A Multicenter Study.
Yin R; Dou Z; Wang Y; Zhang Q; Guo Y; Wang Y; Chen Y; Zhang C; Li H; Jian X; Qi L; Ma W
Acad Radiol; 2024 Apr; ():. PubMed ID: 38693025
[TBL] [Abstract][Full Text] [Related]
15. A descriptive study of the clinico-pathological and surgical characteristics of patients with primary epithelial ovarian cancer. A cross sectional study.
Sindiani A; Obeidat B; Hamadeh L; Alghazo S; Al-Mohtaseb A; Alshdaifat E
Ann Med Surg (Lond); 2020 Nov; 59():254-257. PubMed ID: 33101665
[TBL] [Abstract][Full Text] [Related]
16. Targeting metabolic fluxes reverts metastatic transitions in ovarian cancer.
Arora G; Banerjee M; Langthasa J; Bhat R; Chatterjee S
iScience; 2023 Nov; 26(11):108081. PubMed ID: 37876796
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma.
Ma Y; Luo Y; Lin N; Lv Y; Zhou Y; Li B; Han K; Jiang S; Gao J
Onco Targets Ther; 2018; 11():3659-3670. PubMed ID: 29983574
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2018 May; 28(5):2107-2114. PubMed ID: 29260365
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Lee M; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2017 Nov; 27(11):4510-4515. PubMed ID: 28593431
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
